Ballicules.com

Cefadroxil

DURICEF

What it isPBP-inhibiting first-generation cephalosporin; skin, urinary, and pharyngeal infections.

Why this oneIts longer action permits once-daily treatment of streptococcal pharyngitis, reducing dosing burden versus cephalexin.

What limits itNo MRSA cover. Hypersensitivity; renally adjusted.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Uncomplicated lower UTI (cystitis)Adults1–2 g/day QD or BID1–2 g/day QD or BID2 g/day
Other UTIAdults2 g/day BID2 g/day BID2 g/day
Skin/skin-structure infectionAdults1 g/day QD or BID1 g/day QD or BID1 g/day
GABHS pharyngitis/tonsillitisAdults1 g/day QD or BID ×10 days1 g/day QD or BID1 g/day
UTIChildren30 mg/kg/day divided q12h30 mg/kg/day divided q12h
Pharyngitis/tonsillitis/impetigoChildren30 mg/kg/day QD or divided q12h30 mg/kg/day QD or q12h
Other skin/skin-structure infectionChildren30 mg/kg/day divided q12h30 mg/kg/day divided q12h

Renal Adjust per CrCl: initial 1 g, then 500 mg maintenance — q12h (CrCl 25–50), q24h (10–25), q36h (0–10 mL/min); CrCl >50 treat as normal

Hepatic Undefined

Instructions

Cautions

Adverse reactions

Pregnancy Undefined

Lactation Undefined

NO BOXED WARNINGS

Principal riskHypersensitivity

Cost, est. cash$5–$150/month

Generic entry1982

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk0 / 4

Legacy pregnancy categoryB

Defining liabilityAllergy, gastrointestinal effects and agent-specific renal, hepatic, hematologic or interaction risks.

Mechanism of action: Cefadroxil ballicule

Cefadroxil ballicule: receptor binding, kinetics and half-life diagram

Open Cefadroxil in the interactive console ↗